2025. Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression. Journal of Analytical Oncology. 14, (Oct. 2025), 49–61. DOI:https://doi.org/10.30683/1927-7229.2025.14.09.